425: Strive CEO Comments on Semler Scientific Merger

Strive's CEO Matthew Cole posted on X.com about the proposed business combination with Semler Scientific, reiterating the ongoing merger process.

Summary

• The filing is a Form 425, which re-files a communication posted on X.com by Matthew Cole, CEO of Strive, Inc., on November 14, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc.
• It includes a comprehensive cautionary statement regarding forward-looking statements, outlining various risks associated with the proposed merger.
• Investors are directed to the Registration Statement on Form S-4 and other SEC filings for detailed information about the transaction.
• The filing identifies potential participants in the solicitation of proxies from Semler Scientific stockholders for the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure of a social media post, primarily focused on cautionary statements and procedural information regarding a merger. It contains no new positive or negative operational news.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to unfulfilled conditions.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets.
• Impact of general economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes.
• The integration of the two companies may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction may be more expensive or take longer to complete than expected due to unforeseen factors.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before the closing of the transaction.
• Other unknown or unpredictable factors that could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Management anticipates strategic and financial benefits from the proposed transaction, expecting a positive impact on the combined company's future financial performance. The timing of the closing and the successful integration of the businesses are also forward-looking expectations.

Management Comments

• Matthew Cole, CEO of Strive, Inc., communicated about the ongoing proposed business combination with Semler Scientific, Inc., via X.com, reinforcing the company's commitment to the transaction.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that the combined entity may be exploring or implementing strategies involving digital assets, aligning with a growing trend among some companies to incorporate cryptocurrencies into their treasury management or strategic operations.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's issuance of additional Class A common stock; Semler Scientific stockholders will vote on the proposed transaction.
• Customers: Potential adverse reactions or changes to business relationships.
• Employees: Potential changes to employee relationships.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• The proposed transaction is expected to close, subject to the satisfaction of closing conditions.

Key Dates

Keywords

Merger, Acquisition, Business Combination, Strive Inc., Semler Scientific Inc., SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury, Digital Assets